Marshall Wace’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.8M | Buy |
133,815
+14,374
| +12% | +$671K | 0.01% | 1153 |
|
|
2025
Q4 | $3.52M | Sell |
119,441
-145,932
| -55% | -$3.96M | ﹤0.01% | 1314 |
|
|
2025
Q3 | $6.85M | Buy |
+265,373
| New | +$7.4M | 0.01% | 1069 |
|
|
2024
Q3 | – | Sell |
-35,200
| Closed | -$4.18M | – | 2818 |
|
|
2024
Q2 | $4.18M | Buy |
35,200
+26,300
| +296% | +$3.33M | 0.01% | 1076 |
|
|
2024
Q1 | $948K | Sell |
8,900
-68,000
| -88% | -$6.85M | ﹤0.01% | 1678 |
|
|
2023
Q4 | $7.65M | Buy |
76,900
+71,142
| +1,236% | +$5.98M | 0.01% | 764 |
|
|
2023
Q3 | $595K | Sell |
5,758
-3,242
| -36% | -$362K | ﹤0.01% | 1665 |
|
|
2023
Q2 | $1.09M | Buy |
9,000
+6,839
| +316% | +$912K | ﹤0.01% | 1676 |
|
|
2023
Q1 | $332K | Sell |
2,161
-287,481
| -99% | -$47.4M | ﹤0.01% | 2260 |
|
|
2022
Q4 | $52M | Sell |
289,642
-380,659
| -57% | -$62.2M | 0.13% | 192 |
|
|
2022
Q3 | $79.3M | Buy |
670,301
+44,546
| +7% | +$6.76M | 0.2% | 117 |
|
|
2022
Q2 | $89.4M | Sell |
625,755
-183,380
| -23% | -$26.2M | 0.2% | 116 |
|
|
2022
Q1 | $139M | Buy |
809,135
+763,285
| +1,665% | +$129M | 0.29% | 71 |
|
|
2021
Q4 | $11.6M | Buy |
45,850
+42,828
| +1,417% | +$12.5M | 0.02% | 761 |
|
|
2021
Q3 | $1.16M | Buy |
3,022
+338
| +13% | +$125K | 0.01% | 1929 |
|
|
2021
Q2 | $631K | Sell |
2,684
-67,483
| -96% | -$12.1M | ﹤0.01% | 2026 |
|
|
2021
Q1 | $9.19M | Sell |
70,167
-182,117
| -72% | -$26.4M | 0.05% | 498 |
|
|
2020
Q4 | $26.4M | Buy |
+252,284
| New | +$25.5M | 0.17% | 143 |
|
|
2020
Q3 | – | Sell |
-34,979
| Closed | -$2.25M | – | 1806 |
|
|
2020
Q2 | $2.25M | Buy |
+34,979
| New | +$1.92M | 0.02% | 747 |
|
|
2019
Q3 | – | Sell |
-114,512
| Closed | -$1.68M | – | 1841 |
|
|
2019
Q2 | $1.68M | Buy |
+114,512
| New | +$2.46M | 0.01% | 818 |
|
Other funds holding MRNA
VCM
VPM
